Posttransplantation lymphoproliferative disorder in cardiac transplant allografts

Annals of Thoracic Surgery

Volumn 64, Issue 6, 1997, Pages 1822-1824

  Ying, Alan J ^a   Myerowitz, P David ^a   Marsh Jr , William L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE;

ADULT; ARTICLE; CANDIDIASIS; CARDIOMYOPATHY; CASE REPORT; CAUSE OF DEATH; ECHOCARDIOGRAPHY; HEART GRAFT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE;

HEART TRANSPLANTATION; HEART VALVE DISEASES; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031416392     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01044-8     Document Type: Article

References (15)

1. Armitage JM, Kormos RL, Stuart RS, et al. Posttransplantation lymphoproliferative disease in thoracic organ transplant patients ten years of cyclosporine-based immunosuppression . J Heart Lung Transplant. 10:1991;877-886.
2. Cohen J. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine. 70:1991;137-160.
3. Harris KM, Schwartz ML, Slasky BS, Nalesnik M, Makowka L. Posttransplantation cyclosporine-induced lymphoproliferative disorders clinical and radiologic manifestations . Radiology. 162:1987;697-700.
4. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 7:1993;431-445.
5. Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood. 86:1995;3333-3340.
6. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 133:1988;173-192.
7. Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci. 4:1994;61-79.
8. Eisen HJ, Hicks D, Kant JA, et al. Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. J Heart Lung Transplant. 13:1994;241-245.
9. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol. 103:1995;748-755.
10. Abu-Farsakh H, Cagle PT, Buffone GJ, Bruner JM, Weilbaecher D, Greenberg SD. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder. Arch Pathol Lab Med. 116:1992;93-95.
11. Burtin P, Guerci A, Boman F, et al. Malignant lymphoma in the donor heart after heart transplantation. Eur Heart J. 14:1993;1143-1145.
12. Gambacorta M, Bonacina E, Falini B, Sabattini E, Pileri S. Malignant lymphoma in the recipient of a heart transplant from a donor with malignant lymphoma lymphoma transplantation or de novo disease? Transplantation. 51:1990;920-922.
13. Hanasono MM, Kamel OW, Chang PP, Rizeq MN, Billingham ME, van de Rijn M. Detection of Epstein-Barr virus in cardiac biopsies of heart transplant patients with lymphoproliferative disorders. Transplantation. 60:1995;471-473.
14. Sibley RK, Olivari MT, Bolman RM, Ring WS. Endomyocardial biopsy in the cardiac allograft recipient a review of 570 biopsies . Ann Surg. 203:1986;177-187.
15. Margolin DA, Fabian V, Mintz U, Botham MJ. Primary cardiac lymphoma. Ann Thorac Surg. 61:1996;1000-1001.